Seattle Genetics Trial Fills Up | Xconomy
Monday, August 24th, 2009
Seattle Genetics, the Bothell, WA-based developer of cancer drugs, said today that it has completed enrollment in the pivotal clinical trial of its lead product.
See the rest here:
Seattle Genetics Trial Fills Up | Xconomy
Tags: bothell, clinical-trial, genetics, its-lead, pivotal, said-today, the-pivotal
This entry was posted
on Monday, August 24th, 2009 at 9:24 am and is filed under Seattle News.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.
